BOD Science Ltd (BOD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.175x

Based on the latest financial reports, BOD Science Ltd (BOD) has a cash flow conversion efficiency ratio of -0.175x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$900.22K ≈ $636.96K USD) by net assets (AU$-5.15 Million ≈ $-3.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of BOD Science Ltd for the company's overall valuation and market capitalisation.

BOD Science Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how BOD Science Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

BOD Science Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BOD Science Ltd ranked by their cash flow conversion efficiency. Explore BOD Science Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Impera Capital S.A. WAR:IMP	-0.010x
Zeb Nickel Corp V:ZBNI	0.003x
GSS Infotech Limited NSE:GSS	-0.041x
TGB Banquets And Hotels Limited NSE:TGBHOTELS	-0.039x
Beauce Gold Fields Inc V:BGF	-0.059x
Ridgetech, Inc. NASDAQ:RDGT	-0.165x
FIRST CLASS MET. LS-001 F:WN9	N/A
Prima Cakrawala Abadi PT JK:PCAR	0.183x

Annual Cash Flow Conversion Efficiency for BOD Science Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of BOD Science Ltd from 2016 to 2025. View BOD Science Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-5.15 Million ≈ $-3.65 Million	AU$937.08K ≈ $663.04K	-0.182x	-205.79%
2024-06-30	AU$-5.32 Million ≈ $-3.76 Million	AU$-913.98K ≈ $-646.70K	0.172x	-97.87%
2023-06-30	AU$-703.36K ≈ $-497.67K	AU$-5.68 Million ≈ $-4.02 Million	8.072x	+770.07%
2022-06-30	AU$3.47 Million ≈ $2.45 Million	AU$-4.18 Million ≈ $-2.96 Million	-1.205x	-78.87%
2021-06-30	AU$8.66 Million ≈ $6.13 Million	AU$-5.83 Million ≈ $-4.13 Million	-0.674x	-0.44%
2020-06-30	AU$4.81 Million ≈ $3.40 Million	AU$-3.22 Million ≈ $-2.28 Million	-0.671x	+78.63%
2019-06-30	AU$2.07 Million ≈ $1.46 Million	AU$-6.48 Million ≈ $-4.59 Million	-3.137x	-177.39%
2018-06-30	AU$2.62 Million ≈ $1.85 Million	AU$-2.96 Million ≈ $-2.10 Million	-1.131x	-43.54%
2017-06-30	AU$3.00 Million ≈ $2.12 Million	AU$-2.36 Million ≈ $-1.67 Million	-0.788x	-1925.02%
2016-06-30	AU$5.52 Million ≈ $3.91 Million	AU$-214.91K ≈ $-152.07K	-0.039x	--

About BOD Science Ltd

AU:BOD Australia Drug Manufacturers - Specialty & Generic

Market Cap

$3.01 Million

AU$4.26 Million AUD

Market Cap Rank

#29548 Global

#1669 in Australia

Share Price

AU$0.02

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.02

All Time High

AU$0.67